Literature DB >> 20876488

CADASIL: experimental insights from animal models.

Cenk Ayata1.   

Abstract

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) syndrome is the most common monogenic inherited form of small vessel disease, characterized by frequent migraine attacks with aura, recurrent strokes and progressive white matter degeneration. Early vascular cognitive impairment progresses into frank dementia of subcortical type later in life. Linked to mutations in the NOTCH3 gene, CADASIL vasculopathy is associated with accumulation of granular osmiophilic material and NOTCH3 extracellular domain around small caliber arteries and arterioles, and eventual loss of vascular smooth muscle cells. Cerebral blood flow dysregulation has been hypothesized as a major mechanism, largely based on evidence from hemodynamic studies in CADASIL patients. Although animal models expressing CADASIL mutations reproduced the pathology and cerebrovascular dysfunction, the phenotypic spectrum has been quite heterogeneous, possibly due to the choice of genetic constructs and obvious species differences between mouse and man. Nevertheless, these experimental models provide new opportunities to explore the molecular and physiological mechanisms of CADASIL, and address the fundamental question of whether CADASIL phenotype represents loss of NOTCH3 function or gain of a novel and pathological function. Here, I provide an overview of existing animal models of CADASIL and the pathophysiological insights gained from these models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876488      PMCID: PMC2953736          DOI: 10.1161/STROKEAHA.110.595207

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  56 in total

Review 1.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Quantitative MRI in CADASIL: correlation with disability and cognitive performance.

Authors:  M Dichgans; M Filippi; R Brüning; G Iannucci; C Berchtenbreiter; L Minicucci; I Uttner; A Crispin; H Ludwig; T Gasser; T A Yousry
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

3.  Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients.

Authors:  A Joutel; K Vahedi; C Corpechot; A Troesch; H Chabriat; C Vayssière; C Cruaud; J Maciazek; J Weissenbach; M G Bousser; J F Bach; E Tournier-Lasserve
Journal:  Lancet       Date:  1997-11-22       Impact factor: 79.321

4.  Endothelial changes in muscle and skin biopsies in patients with CADASIL.

Authors:  M M Ruchoux; C A Maurage
Journal:  Neuropathol Appl Neurobiol       Date:  1998-02       Impact factor: 8.090

5.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

Authors:  A Joutel; C Corpechot; A Ducros; K Vahedi; H Chabriat; P Mouton; S Alamowitch; V Domenga; M Cécillion; E Marechal; J Maciazek; C Vayssiere; C Cruaud; E A Cabanis; M M Ruchoux; J Weissenbach; J F Bach; M G Bousser; E Tournier-Lasserve
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

6.  Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.

Authors:  Marie Monet-Leprêtre; Boris Bardot; Barbara Lemaire; Valérie Domenga; Ophélia Godin; Martin Dichgans; Elisabeth Tournier-Lasserve; Michel Cohen-Tannoudji; Hugues Chabriat; Anne Joutel
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

7.  Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL.

Authors:  Yumi Yamamoto; Masafumi Ihara; Carina Tham; Roger W C Low; Janet Y Slade; Tim Moss; Arthur E Oakley; Tuomo Polvikoski; Raj N Kalaria
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

Review 8.  Cadasil.

Authors:  Hugues Chabriat; Anne Joutel; Martin Dichgans; Elizabeth Tournier-Lasserve; Marie-Germaine Bousser
Journal:  Lancet Neurol       Date:  2009-07       Impact factor: 44.182

9.  The phenotypic spectrum of CADASIL: clinical findings in 102 cases.

Authors:  M Dichgans; M Mayer; I Uttner; R Brüning; J Müller-Höcker; G Rungger; M Ebke; T Klockgether; T Gasser
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

10.  Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients.

Authors:  Saara Tikka; Kati Mykkänen; Marie-Magdeleine Ruchoux; Robert Bergholm; Maija Junna; Minna Pöyhönen; Hannele Yki-Järvinen; Anne Joutel; Matti Viitanen; Marc Baumann; Hannu Kalimo
Journal:  Brain       Date:  2009-01-27       Impact factor: 13.501

View more
  28 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Vascular cognitive impairment: introduction.

Authors:  Costantino Iadecola; Vladimir Hachinski; Gary A Rosenberg
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease.

Authors:  Fabrice Dabertrand; Christel Krøigaard; Adrian D Bonev; Emmanuel Cognat; Thomas Dalsgaard; Valérie Domenga-Denier; David C Hill-Eubanks; Joseph E Brayden; Anne Joutel; Mark T Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 4.  Cerebral microhemorrhages: mechanisms, consequences, and prevention.

Authors:  Zoltan Ungvari; Stefano Tarantini; Angelia C Kirkpatrick; Anna Csiszar; Calin I Prodan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 5.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

Review 6.  Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.

Authors:  Akihiro Shindo; Anna C Liang; Takakuni Maki; Nobukazu Miyamoto; Hidekazu Tomimoto; Eng H Lo; Ken Arai
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 7.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

8.  HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.

Authors:  Jackson T Fontaine; Amanda C Rosehart; Anne Joutel; Fabrice Dabertrand
Journal:  Mech Ageing Dev       Date:  2020-10-27       Impact factor: 5.432

Review 9.  The vascular neural network--a new paradigm in stroke pathophysiology.

Authors:  John H Zhang; Jerome Badaut; Jiping Tang; Andre Obenaus; Richard Hartman; William J Pearce
Journal:  Nat Rev Neurol       Date:  2012-10-16       Impact factor: 42.937

Review 10.  Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition.

Authors:  Diewertje I Bink; Katja Ritz; Eleonora Aronica; Louise van der Weerd; Mat J A P Daemen
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.